FTC Challenges Asthma Product Patents Listed With FDA
The Federal Trade Commission challenged over 100 patents related to asthma treatment held by 10 major pharmaceutical companies including AstraZeneca, Teva and GlaxoSmithKline on Tuesday, claiming that the drug manufacturers listed...To view the full article, register now.
Already a subscriber? Click here to view full article